{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:07:13Z","timestamp":1784786833179,"version":"3.55.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify symptom trajectory types during recovery from AECOPD using GBTM, explore the role of admission systemic inflammatory burden (assessed by CRP and PCT) in shaping recovery heterogeneity, and analyze the association between trajectory types and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 216 AECOPD patients hospitalized between January 2023 and December 2024 were enrolled. CAT and mMRC were used to assess symptom changes at 7 time points from admission to 12 weeks post-discharge. Admission systemic inflammatory biomarkers (CRP and PCT) were collected as biomarkers of inflammatory burden. Sepsis was defined according to Sepsis-3 criteria as life-threatening organ dysfunction caused by a dysregulated host response to infection, identified by an acute SOFA score increase of \u22652 points. Available SOFA components included the respiratory sub-score (derived from PaO2\/FiO2) and the coagulation sub-score; hepatic, renal, cardiovascular, and neurological sub-scores were not systematically collected. Accordingly, formal complete SOFA-based Sepsis-3 classification was not feasible; CRP and PCT are used herein as surrogate biomarkers of systemic inflammatory burden alongside partial SOFA data. GBTM was applied using the traj procedure in SAS 9.4 to identify symptom recovery trajectory types, and baseline characteristics and prognostic differences were compared among trajectory groups. Cox proportional hazards regression and Fine-Gray competing risk models were used to analyze the association between trajectory types and first re-exacerbation risk. Negative binomial regression was used to analyze the association between trajectory types and re-exacerbation and rehospitalization frequency. Multivariable logistic regression was used to identify independent predictors of non-rapid recovery trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four symptom recovery trajectory types were identified: rapid recovery group (82 cases, 38.0%), slow recovery group (62 cases, 28.7%), persistent symptoms group (48 cases, 22.2%), and symptom rebound group (24 cases, 11.1%). Patients in non-rapid recovery groups exhibited significantly higher admission inflammatory biomarker levels (CRP and PCT) compared to the rapid recovery group (all P &amp;lt; 0.05). The median time to first re-exacerbation was 248, 156, 78, and 102 days, respectively (P &amp;lt; 0.001). Multivariable Cox regression showed that, using the rapid recovery group as reference, the slow recovery group (aHR = 1.62, 95%CI: 1.08\u20132.42), persistent symptoms group (aHR = 2.58, 95%CI: 1.68\u20133.96), and symptom rebound group (aHR = 2.24, 95%CI: 1.32\u20133.80) all had elevated first re-exacerbation risk (all P &amp;lt; 0.05). Negative binomial regression showed that non-rapid recovery groups had increased re-exacerbation and rehospitalization counts within 12 months (all P &amp;lt; 0.05). Higher admission CAT score (OR = 1.18), lower FEV1%pred (OR = 0.96), \u22652 exacerbations in the previous year (OR = 2.42), higher admission CRP (OR = 1.01, an admission inflammatory biomarker), and current smoking (OR = 2.15) were independent predictors of non-rapid recovery trajectory (all P &amp;lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Symptom trajectories during AECOPD recovery are heterogeneous, and elevated admission systemic inflammatory burden is associated with non-rapid recovery. Non-rapid recovery trajectories are associated with increased re-exacerbation risk and worse quality of life. Trajectory-based prognostic stratification combined with early inflammatory burden assessment may facilitate identification of high-risk patients and development of individualized follow-up management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1845159","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:41:17Z","timestamp":1784785277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptom trajectory types during recovery from acute exacerbation of COPD and their association with systemic inflammatory burden and prognosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Xianju Hospital of Traditional Chinese Medicine","place":["Taizhou City, Zhejiang Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Pujiang Hospital of Traditional Chinese Medicine, Pujiang","place":["Zhejiang Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur. Respir. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1164\/rccm.202310-1773OC","article-title":"Severity of airflow obstruction based on FEV1\/FVC versus FEV1 percent predicted in the general U.S. population","volume":"210","author":"Backman","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2147\/COPD.S374129","article-title":"A longitudinal study of trajectories and factors influencing patient-reported outcomes in chronic obstructive pulmonary disease","volume":"17","author":"Cai","year":"2022","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/17476348.2023.2239708","article-title":"Up-to-date guidance towards improving medication adherence in patients with chronic obstructive pulmonary disease","volume":"17","author":"Case","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12890-024-03346-6","article-title":"Factors related to the progression of chronic obstructive pulmonary disease: a retrospective case-control study","volume":"25","author":"Ding","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/jcm13133855","article-title":"CRP, fibrinogen, white blood cells, and blood cell indices as prognostic biomarkers of future COPD exacerbation frequency: the TIE cohort study","volume":"13","author":"Ellingsen","year":"2024","journal-title":"J. Clin. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gastrohep.2023.12.005","article-title":"Tips and tricks for successfully conducting a multicenter study","volume":"47","author":"Gisbert","year":"2024","journal-title":"Gastroenterol. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MLR.0000000000000940","article-title":"Time-varying readmission diagnoses during 30 days after hospitalization for COPD exacerbation","volume":"56","author":"Goto","year":"2018","journal-title":"Med. Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100619","DOI":"10.1016\/j.lanepe.2023.100619","article-title":"Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study","volume":"29","author":"Halpin","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e65143","DOI":"10.2196\/65143","article-title":"Utility of consumer-grade wearable devices for inferring physical and mental health outcomes in severe mental illness: systematic review","volume":"12","author":"Hassan","year":"2025","journal-title":"JMIR Ment. Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42234-023-00115-4","article-title":"Objective wearable measures and subjective questionnaires for predicting response to neurostimulation in people with chronic pain","volume":"9","author":"Heros","year":"2023","journal-title":"Bioelectron. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12931-022-02123-5","article-title":"Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review","volume":"23","author":"Hurst","year":"2022","journal-title":"Respir. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/crj.13606","article-title":"A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease","volume":"17","author":"Ji","year":"2023","journal-title":"Clin. Respir. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1753466620961688","DOI":"10.1177\/1753466620961688","article-title":"Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Jo","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a Stata plugin for estimating group-based trajectory models","volume":"42","author":"Jones","year":"2013","journal-title":"Sociol. Methods Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociol. Methods Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2147\/JHC.S456093","article-title":"Limited generalizability of retrospective single-center cohort study in comparison to multicenter cohort study on prognosis of hepatocellular carcinoma","volume":"11","author":"Kim","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1346491","DOI":"10.3389\/fimmu.2024.1346491","article-title":"The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses","volume":"15","author":"Kortekaas","year":"2024","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41533-023-00339-6","article-title":"Modelling 30-day hospital readmission after discharge for COPD patients based on electronic health records","volume":"33","author":"Li","year":"2023","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18332\/tid\/156047","article-title":"How does cigarette smoking affect airway remodeling in asthmatics?","volume":"21","author":"Lin","year":"2023","journal-title":"Tob. Induc. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.pulmoe.2022.04.004","article-title":"Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: a scoping review","volume":"29","author":"Machado","year":"2023","journal-title":"Pulmonology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2102006","DOI":"10.1183\/13993003.02006-2021","article-title":"ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations","volume":"59","author":"Mathioudakis","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4159\/9780674041318","author":"Nagin","year":"2005","journal-title":"Group-based modeling of development"},{"key":"B23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12931-024-03033-4","article-title":"Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis","volume":"25","author":"Xu","year":"2024","journal-title":"Respir. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s40001-025-02966-w","article-title":"Development and validation of a nomogram model for predicting one-year unplanned readmission in patients with chronic obstructive pulmonary disease","volume":"30","author":"Zhu","year":"2025","journal-title":"Eur. J. Med. Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1845159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:41:17Z","timestamp":1784785277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1845159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":26,"alternative-id":["10.3389\/fcell.2026.1845159"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1845159","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1845159"}}